What is NIPH's market capitalization?

El-Nile Co. for Pharmaceuticals & Chemical Industries has a market capitalization of about EGP 12.72B.

Does NIPH pay dividends?

Yes — El-Nile Co. for Pharmaceuticals & Chemical Industries paid EGP 2 per share for fiscal 2025, a dividend yield of 0.79% at the last price.

What is NIPH's P/E ratio?

El-Nile Co. for Pharmaceuticals & Chemical Industries trades at a trailing price-to-earnings ratio of 40.88.

What sector is El-Nile Co. for Pharmaceuticals & Chemical Industries in?

El-Nile Co. for Pharmaceuticals & Chemical Industries is listed on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector.

Where can I track NIPH?

This Starta Markets page shows El-Nile Co. for Pharmaceuticals & Chemical Industries's EGX quote (delayed 15 minutes), key statistics, financial statements, dividends, technicals and news, in Arabic and English.

El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH) Share Price — EGX

EGP 254.5+5.16%Indicator average: −0.31 (−1 to +1)

El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH) trades on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector. Last updated 28 Oct 2026, 14:30 (Cairo time).

What is El-Nile Co. for Pharmaceuticals & Chemical Industries’s share price today? NIPH last traded at EGP 254.5 (+5.16% on the day), for a market value of EGP 12.72 billion, a P/E of 40.88 and a dividend yield of 0.79%. Its 52-week range is EGP 87 to 516.96.

NIPH price performance

1W: -5.4%
1M: -14.7%
3M: +13.1%
6M: +94.8%
YTD: +153.9%
1Y: +93.2%
5Y: —

Price change from EGX closing prices, adjusted for recorded splits and bonus issues; cash dividends are not included. A period that spans an unexplained price jump is not shown. Past performance does not indicate future results.

About El-Nile Co. for Pharmaceuticals & Chemical Industries

El-Nile Co. for Pharmaceuticals & Chemical Industries engages in the manufacture and sale of pharmaceuticals, chemicals, cosmetics, and medical supplies.Its products include analgesic, anti-inflammatory, anesthetic, anti-diabetics, and antiseptic medicines; skin preparations and hair tonics; and vitamins and minerals.The company was founded in 1962 and is headquartered in Cairo, Egypt.

Industry:: Pharmaceuticals: Major
Employees:: 2,500
CEO:: Khalid Salahuddin Mahmoud Haggage
ISIN:: EGS38331C012
Website:: www.nilepharma.com.eg

NIPH key statistics

Last price: EGP 254.5
Previous close: EGP 242.01
Day change: 5.16%
52-week range: EGP 87 – 516.96
Volume: 992,981
Shares outstanding: 50M
Free float: 28.33%
Market cap: EGP 12.72B
P/E (trailing): 40.88
P/B: 15.43
Dividend yield (FY 2025): 0.79%
EPS (TTM): EGP 6.23
Revenue (TTM): EGP 2.24B
Net income (TTM): EGP 240.13M
ROE: 20.75%
Book value / share: EGP 22.07
Beta (1Y): 1
50-day MA: EGP 316.18
200-day MA: EGP 191.32
RSI (14): 41.63

Data as of 28 Oct 2026, 14:30 (Cairo time). EGX market data; financial statements from company disclosures. Prices are delayed 15 minutes during EGX trading hours (Sun–Thu).

Compare with other Health Care & Pharmaceuticals stocks

Latest El-Nile Co. for Pharmaceuticals & Chemical Industries news

El-Nile for Pharmaceuticals logs 155% leap in H1-25/26 net profits1 Feb 2026

Key terms behind the NIPH figures

Market Capitalization: Market capitalization is the total market value of a company’s outstanding shares, calculated as the share price multiplied by the number of issued shares. It is the standard measure used to rank the size of listed companies and to weight them in indices such as the EGX 30. Market cap changes continuously as the share price moves.
Price-to-Earnings (P/E) Ratio: The price-to-earnings ratio divides a company’s share price by its earnings per share, showing how many pounds investors pay for each pound of annual profit. It is one of the most widely used valuation multiples for comparing listed companies within the same sector. A trailing P/E uses reported earnings, while a forward P/E uses forecast earnings.
Price-to-Book (P/B) Ratio: The price-to-book ratio compares a company’s share price with its book value per share, which is shareholders’ equity divided by the number of shares. A ratio of 1 means the stock trades at exactly its accounting net worth. The multiple is used widely for valuing banks and other asset-heavy businesses on the EGX.
Dividend Yield: Dividend yield is the annual cash dividend per share expressed as a percentage of the current share price. It measures the income a shareholder receives from distributions relative to the market price of the stock. Because the calculation uses the market price, the yield rises when the price falls and falls when the price rises, assuming the dividend is unchanged.

Frequently asked questions

What is El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH) share price today?: El-Nile Co. for Pharmaceuticals & Chemical Industries last traded at EGP 254.5 on the Egyptian Exchange (as of 28 Oct 2026, 14:30, Cairo time). Prices update every 15 minutes during EGX trading hours.
What is NIPH's market capitalization?: El-Nile Co. for Pharmaceuticals & Chemical Industries has a market capitalization of about EGP 12.72B.
Does NIPH pay dividends?: Yes — El-Nile Co. for Pharmaceuticals & Chemical Industries paid EGP 2 per share for fiscal 2025, a dividend yield of 0.79% at the last price.
What is NIPH's P/E ratio?: El-Nile Co. for Pharmaceuticals & Chemical Industries trades at a trailing price-to-earnings ratio of 40.88.
What sector is El-Nile Co. for Pharmaceuticals & Chemical Industries in?: El-Nile Co. for Pharmaceuticals & Chemical Industries is listed on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector.
Where can I track NIPH?: This Starta Markets page shows El-Nile Co. for Pharmaceuticals & Chemical Industries's EGX quote (delayed 15 minutes), key statistics, financial statements, dividends, technicals and news, in Arabic and English.